Annual report pursuant to Section 13 and 15(d)

Stockholders??? Equity (Tables)

v3.24.1
Stockholders’ Equity (Tables)
12 Months Ended
Dec. 31, 2023
Stockholders’ Equity [Abstract]  
Schedule of Assumptions Used in the Black-Scholes Model The assumptions used in the Black-Scholes Model are set forth in the table below.
    December 31,
2023
 
Stock price   $ 1.14-2.00  
Risk-free interest rate     4.09-4.70%  
Volatility     50.64-55.34%  
Expected life in years     0.12-5.00  
Dividend yield     0.00%  
    2023     2022  
Stock price   $ 1.24 – $2.06     $ 3.81 – $6.55  
Risk-free interest rate     3.61 – 4.82%       1.82 – 3.95%  
Volatility     49.83 – 58.92%       46.42 – 48.96%  
Expected life in years     0.12 – 6.25       5.80 – 6.30  
Dividend yield     0.00%       0.00%  

  

Schedule of Warrants Activity A summary of our Warrants activity and related information follows:
    Number of Shares Under Warrant     Weighted Average Exercise Price     Weighted
Average
Remaining
Contractual
Life
 
Balance as of January 1, 2022     3,305,854     $ 8.53       5.20  
Expired     (1,404,052 )   $ 9.75          
Balance as of December 31, 2022     1,901,802     $ 7.63       7.47  
Granted     10,786,440     $ 1.38          
Expired     (122,150 )   $ 12.35          
Balance as of December 31, 2023     12,566,092     $ 2.22       4.71  
Schedule of Stock Option Activity A summary of our Option activity and related information follows:
    Number of Shares Under Option     Weighted Average Exercise Price     Weighted
Average
Remaining
Contractual
Life
 
Balance as of January 1, 2022     687,448     $ 6.79       8.20  
Granted     2,094,000     $ 5.17          
Exercised     (31,057 )   $ 2.09          
Forfeited     (168,105 )   $ 2.77          
Canceled     (170,000 )   $ 6.43          
Balance as of December 31, 2022     2,412,286     $ 5.77       7.58  
Granted     3,451,321     $ 3.63          
Exercised     (89,042 )   $ 0.49          
Forfeited     (673,292 )   $ 3.90          
Canceled     (246,766 )   $ 6.03          
Balance as of December 31, 2023     4,854,507     $ 4.59       7.34  
Vested and Exercisable as of December 31, 2023     2,118,648     $ 6.62       5.19  
Schedule of Stock-Based Compensation Expense for Stock Options Total stock-based compensation expense for stock options for the years ended December 31, 2023 and 2022 is as follows:
    Years Ended
December 31,
 
    2023     2022  
General and administrative   $ 343,371     $ 536,269  
Sales and marketing     523,798       509,789  
Research and development     223,513       720,554  
Cost of goods sold     50,341       -  
Total stock-based expense related to options   $ 1,141,023     $ 1,766,612  
Total stock-based compensation expense for RSUs for the years ended December 31, 2023 and 2022 is as follows:
    Years Ended
December 31,
 
    2023     2022  
General and administrative   $ (152,814 )   $ 3,259,648  
Sales and marketing     90,899       24,632  
Research and development     (31,710 )     806,543  
Total stock-based expense related to RSUs   $ (93,625 )   $ 4,090,823  
Schedule of Restricted Stock Unit Activity A summary of our RSUs activity and related information follows:
    RSUs     Weighted Average Grant Date Fair Value     Weighted
Average
Vesting Period (Years)
 
Unvested balance at January 1, 2022     1,431,922     $ 12.12       2.5  
Granted     190,860     $ 2.52          
Vested     (512,755 )   $ 8.06          
Canceled     -     $ -          
Unvested balance at December 31, 2022     1,110,027     $ 6.89       1.52  
Granted     722,682     $ 0.66          
Vested     (823,143 )   $ 5.00          
Canceled     (455,100 )     7.41          
Unvested balance at December 31, 2023     554,466     $ 1.14       0.66